Testing version — LOERadar is in active testing. Features and data may change.
PAXIL (PAROXETINE HYDROCHLORIDE) | LOERadar
PAXIL
NDA
PAROXETINE HYDROCHLORIDE | N020710 | APOTEX INC
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 10MG BASE/5ML
RLD
0 patents0 exclusivities▴
SUSPENSION;ORAL | Approved: Jun 25, 1997
No patent or exclusivity listings for this strength.